Lupin debuts generic Lidex
Lupin is launching fluocinonide ointment in a 0.05% dosage strength, having previously received the Food and Drug Administration’s approval.
The product is the generic of County Line Pharmaceuticals’ Lidex ointment 0.05%. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Fluocinonide ointment, 0.05% had a market value of approximately $15 million, according to January 2019 IQVIA data.
The product is the generic of County Line Pharmaceuticals’ Lidex ointment 0.05%. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Fluocinonide ointment, 0.05% had a market value of approximately $15 million, according to January 2019 IQVIA data.